Amrubicin monotherapy for elderly patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective study

BACKGROUND: Previous studies have shown amrubicin (AMR) to be an effective second‐line treatment option for small‐cell lung cancer (SCLC). However, the efficacy of AMR in elderly patients with relapsed SCLC has not been sufficiently evaluated. METHODS: The medical records of elderly patients with re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sone, Hideyuki, Igawa, Satoshi, Kasajima, Masashi, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Hosotani, Shinji, Ohe, Shuntaro, Ito, Hiroki, Kaizuka, Nobuki, Manaka, Hiroya, Fukui, Tomoya, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166081/
https://www.ncbi.nlm.nih.gov/pubmed/30126051
http://dx.doi.org/10.1111/1759-7714.12833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166081/
https://www.ncbi.nlm.nih.gov/pubmed/30126051
http://dx.doi.org/10.1111/1759-7714.12833

Ejemplares similares